The news followed an investigation by POLITICO’s E&E News into climate-friendly inhalers and how drug giants are developing them to undermine competition. The pharmaceutical giant AstraZeneca has ...
President Joe Biden’s career-defining victories over Big Pharma — reforming Medicare to lower prices and capping inhaler costs for millions of Americans with lung disease — are facing an unlikely ...
Switching to “green” inhalers for conditions such as asthma could cut greenhouse gas emissions and reduce drug costs, a study suggests. Research led by the University of Cambridge looked at the carbon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback